After different imaging examination methods and routine treatment, ARS patients participating in this trial were compared and analyzed by detecting the expression level of retinol binding protein 4 before and after treatment by enzyme-linked immunosorbent assay (ELISA), and the correlation between CT perfusion imaging and patient prognosis was obtained as shown in Table 3. This evidence concerns the gene RBP4 and Axenfeld-Rieger syndrome.